Abstract
Neurological symptoms and neurodegeneration are silent features of many neuropathological conditions. These include acute metabolic and physiological insult, chronic motor and dementia disorders as well as inflammatory diseases represting important causes of morbidity and mortality in humans. Studies dining the last decade have provided convincing evidence that numerous neuroactive molecules play a vital role in chemical signaling and neurodegenerative processes of the nervous system.1 These substances before mainly represented putative transmitters and neuropeptides. Investigations on oxidative stress involving reactive oxygen species (ROS) and reactive nitrogen species (NOS) are now largely believed to be in part responsible for the induction of neurogenic lesions not only by producing neurotoxins but also leading to DNA adduct formation.2 The interdependence of neuropeptide/neurotransmitter pathways and their co-existence in the same neuron is a tremendous advance to understand how neurosecretion can control the processes of transmitter synthesis, release and metabolism. Receptor active opioid peptides in human brain were demonstrated more than 20 years ago.3 Regardless of our advance knowledge on the neurochemitsry of neuropeptide/neurotransmitter and free radicals, it still remains extremely difficult to have a precise diagnosis of the early onset of neurodegenerative processes and only the post-mortem histopathological and laboratory tests can provide the true neuropathological picture.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
G.A. Qureshi, Sh. Baig, I. Bednar, A. Halawa and S. H. Parvez, The neurochemical markers in cerebrospinal fluid to differentiate between aseptic and tuberculosis meningitis, Neurochem. Int. 32, 197–203 (1998).
N. Acworth, M. Naoi, H. Parvez and S. Parvez, Coulometric Electrode Array Detectors for HPLC (VSP Press, Zeist, The Netherlands 1997), pp. 97–126.
L. Terenius and A. Wahlström, Morphine-like ligand for opioid receptors in human CSF, Life Sci. 13, 1759–1764(1975).
C. Reiss, S. Parvez, G. Labbe and H. Parvez, Advances in Molecular Toxicology (VSP Press, Zeist, The Netherlands 1998), pp.293–312.
G. A. Qureshi, Sh. Baig, and S.H. Parvez, Biochemical markers in tuberculosis meningitis, Biogenic Amines, 12, 499–519(1996).
T. Hökfelt, J. Lundberg, H. Lagercrantz, K. Tatemoto, V. Mutt, J. Lindberg, L. Terenius, B. Everitt, K. Fuxe, L. Agnati and M. Goldstein, Occurrence of neuropeptide Y (NPY)-like immunoreactivity in catecholamine neurons in human medulla oblongata, Neurosci. Lett. 36, 217–222 (1983).
G. A. Qureshi, Sh. Baig, C. Collin and S. H. Parvez, Variations in cerebrospinal fluid levels of neuropeptide Y, cholecystokinin and substance-P in patients with neurological disorders. Neuroendocrinology Lett. 21, 409–416(2000)
H. Saito, H. Togashi, M. Yoshioka, N. Nakamura, M. Minami and S.H. Parvez, Animal models of vascular dementia with emphasis on stroke-prone spontaneously hypertensive rats. Clin. Exp. Pharmacol. Physiol. Suppl.1, S-257-S-259 (1995).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Springer Science+Business Media New York
About this chapter
Cite this chapter
Parvez, H., Baig, S., Collin, C., Qureshi, A., Parvez, S., Reiss, C. (2002). Dynamic Monitoring of Neurological Diseases by CSF Clinical Markers. In: Nagatsu, T., Nabeshima, T., McCarty, R., Goldstein, D.S. (eds) Catecholamine Research. Advances in Behavioral Biology, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-3538-3_121
Download citation
DOI: https://doi.org/10.1007/978-1-4757-3538-3_121
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-3388-1
Online ISBN: 978-1-4757-3538-3
eBook Packages: Springer Book Archive